Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 14,286 | 10,467 | 14,051 | 12,010 | 12,235 |
| Cost of Goods | 8,168 | 7,130 | 10,455 | 9,565 | 7,094 |
| Gross Profit | 6,118 | 3,337 | 3,596 | 2,445 | 5,141 |
| Operating Expenses | 10,158 | 8,758 | 12,477 | 10,661 | 10,290 |
| Operating Income | -3,872 | -5,291 | -8,426 | -7,651 | -5,055 |
| Interest Expense | 583 | 577 | 1,462 | 424 | 430 |
| Other Income | -382 | 20 | 114 | -329 | -103 |
| Pre-tax Income | -4,837 | -5,848 | -9,774 | -8,404 | -5,588 |
| Income Tax | 31 | 1 | 86 | -17 | 23 |
| Net Income Continuous | -4,868 | -5,849 | -9,860 | -8,387 | -5,611 |
| Net Income | $-4,868 | $-5,849 | $-9,860 | $-8,387 | $-5,611 |
| EPS Basic Total Ops | -26.14 | -17.83 | -134.79 | -110.36 | -91.98 |
| EPS Basic Continuous Ops | -8.93 | -17.83 | -135.10 | -110.36 | -91.98 |
| EPS Diluted Total Ops | -26.14 | -17.83 | -134.79 | -110.36 | -91.98 |
| EPS Diluted Continuous Ops | -8.93 | -17.83 | -135.10 | -110.36 | -91.98 |
| EPS Diluted Before Non-Recurring Items | -8.93 | -18.00 | -128.00 | N/A | N/A |
| EBITDA(a) | $-2,341 | $-5,035 | $-7,299 | $-7,463 | $-4,861 |